Less Hunger, more innovation: Ozempic phenomenon is redefining food Industry.

GLP-1 receptor agonists such as Ozempic have transformed the treatment of obesity, also reshaping the relationship with food by suppressing appetite and creating new nutritional challenges. In this context, the food industry has the opportunity to contribute to the well-being of people undergoing treatment with these drugs, helping to sustain their benefits, mitigate side effects, and meet new nutritional needs.